Sheel Biotech Claims Corporate Governance Exemption for Q2 FY27
Sheel Biotech Ltd 路 Others (Uncategorized) 路 13 Oct 2026, 11:23 pm
Sheel Biotech Claims Corporate Governance Exemption for Q2 FY27 Sheel Biotech Limited confirmed the non-applicability of Corporate Governance Report submissions under Regulation 27(2) of SEBI LODR Regulations for the quarter ended 30th Sep'26. The company claimed exemption under Regulation 15(2) due to its listing on the NSE SME Platform, which exempts specified SME-listed entities from standard corporate governance compliance mandates under Regulations 17 to 27. Sheel Biotech stated it will comply with the relevant provisions if they become applicable at a later stage.
Original exchange filing (PDF)
More announcements from Sheel Biotech Ltd
- Sheel Biotech Limited has informed the Exchange regarding 'Investor Presentation'. 路 17 Nov 2026
- Sheel Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 14 Nov 2026
- Sheel Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 13 Nov 2026
- Monitoring Agency Report for the Half year ended on 30th September, 2026. 路 13 Nov 2026
- SHEEL BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 13-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 13 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters 路 13 Nov 2026
- Sheel Biotech Limited has informed the Exchange about receipt of Award of Work having contract value of Rs. 1.72 Crore from Sher-e-Kashmir University of Agricultural Sciences and Technology of Jammu (SKUAST-Jammu) for blueberry production. 路 30 Oct 2026
- Statement of Investor Complaints under Regulation 13(3) of Securities and Exchange Board of India (LODR), 2015 for the quarter ended 30th Sept, 2026. 路 14 Oct 2026
